WallStreetZen

NYSE: MRK
Merck & Co Inc Stock Forecast, Predictions & Price Target

Analyst price target for MRK

Based on 5 analysts offering 12 month price targets for Merck & Co Inc.
Min Forecast
$92.00+20.56%
Avg Forecast
$99.40+30.26%
Max Forecast
$105.00+37.6%

Should I buy or sell MRK stock?

Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

MRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Chris Schott
JP Morgan
Strong BuyMaintains$105.00+37.60%2020-10-16
Terence Flynn
Goldman Sachs
Strong BuyUpgrades$105.00+37.60%2020-08-03
Navin Jacob
UBS
Strong BuyMaintains$92.00+20.56%2020-04-13
Anonymous
Bernstein
BuyReinstates$95.00+24.49%2020-11-10
Daina Graybosch
SVB Leerink
BuyMaintains$100.00+31.04%2020-08-25
Tim Anderson
Wolfe Research
HoldDowngradesN/AN/A2020-06-12

1 of 1

Forecast return on equity

Is MRK forecast to generate an efficient return?
Company
78.6%
Industry
76.5%
Market
32,279.67%
MRK's Return on Equity is forecast to be high in 3 years (78.6%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRK forecast to generate an efficient return on assets?
Company
21.73%
Industry
16.91%
Market
11,627.87%
MRK is forecast to generate higher Return on Assets (21.73%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

MRK earnings per share forecast

What is MRK's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$6.56+135.08%
Avg 2 year Forecast
$6.96+149.46%
Avg 3 year Forecast
$7.43+166.4%
MRK's earnings are forecast to grow at an exceptional rate of 38.52% per year
Forecast

MRK revenue forecast

What is MRK's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$52.1B+8.49%
Avg 2 year Forecast
$54.2B+12.95%
Avg 3 year Forecast
$55.8B+16.25%
MRK's revenue is forecast to grow at a rate of 5.15% per year, which is not exceptional
Forecast

MRK earnings growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
38.52%
Industry
34.05%
Market
23.11%
MRK's earnings are forecast to grow faster (38.52% per year) than the US Drug Manufacturers - General industry average (34.05%)
Forecast
MRK's earnings are forecast to grow faster (38.52% per year) than the US market average (23.11%)
Forecast
MRK's earnings are forecast to grow faster (38.52% per year) than the risk-free savings rate (1.7%)
Forecast

MRK revenue growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
5.15%
Industry
6.04%
Market
15.04%
MRK's revenues are forecast to grow slower (5.15% per year) than the US Drug Manufacturers - General industry average (6.04%)
Forecast
MRK's revenues are forecast to grow slower (5.15% per year) than the US market average (15.04%)
Forecast

Merck & Stock Forecast FAQ

Is Merck & Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: MRK) stock is to Strong Buy MRK stock.

Out of 6 analysts, 3 (50%) are recommending MRK as a Strong Buy, 2 (33.33%) are recommending MRK as a Buy, 1 (16.67%) are recommending MRK as a Hold, 0 (0%) are recommending MRK as a Sell, and 0 (0%) are recommending MRK as a Strong Sell.

What is MRK's earnings growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual earnings growth rate of 38.52% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 34.05%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.11%.

Merck &'s earnings in 2021 is $7,067,000,000.On average, 7 Wall Street analysts forecast MRK's earnings for 2021 to be $16,593,483,859, with the lowest MRK earnings forecast at $16,394,623,152, and the highest MRK earnings forecast at $16,748,827,973. On average, 6 Wall Street analysts forecast MRK's earnings for 2022 to be $17,609,039,682, with the lowest MRK earnings forecast at $15,180,206,622, and the highest MRK earnings forecast at $19,076,459,655.

In 2023, MRK is forecast to generate $18,804,480,953 in earnings, with the lowest earnings forecast at $16,369,322,807 and the highest earnings forecast at $20,316,176,529.

What is MRK's revenue growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual revenue growth rate of 5.15% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.04%.

Merck &'s revenue in 2021 is $47,994,000,000.On average, 4 Wall Street analysts forecast MRK's revenue for 2021 to be $131,740,803,310,590, with the lowest MRK revenue forecast at $130,919,971,588,022, and the highest MRK revenue forecast at $133,013,271,480,507. On average, 4 Wall Street analysts forecast MRK's revenue for 2022 to be $137,156,562,135,984, with the lowest MRK revenue forecast at $125,471,997,834,141, and the highest MRK revenue forecast at $144,513,037,007,003.

In 2023, MRK is forecast to generate $141,155,934,312,548 in revenue, with the lowest revenue forecast at $128,973,565,494,949 and the highest revenue forecast at $149,389,248,278,466.

What is MRK's forecast return on assets (ROA) for 2021-2024?

(NYSE: MRK) forecast ROA is 21.73%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is MRK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year MRK price target, the average MRK price target is $99.40, with the highest MRK stock price forecast at $105.00 and the lowest MRK stock price forecast at $92.00.

On average, Wall Street analysts predict that Merck &'s share price could stay at $99.40 by Nov 10, 2021. The average Merck & stock price prediction forecasts a potential downside of N/A from the current MRK share price of $76.31.

What is MRK's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: MRK) Merck &'s current Earnings Per Share (EPS) is $2.79. On average, analysts forecast that MRK's EPS will be $6.56 for 2021, with the lowest EPS forecast at $6.48, and the highest EPS forecast at $6.62. On average, analysts forecast that MRK's EPS will be $6.96 for 2022, with the lowest EPS forecast at $6.00, and the highest EPS forecast at $7.54. In 2023, MRK's EPS is forecast to hit $7.43 (min: $6.47, max: $8.03).

What is MRK's forecast return on equity (ROE) for 2021-2024?

(NYSE: MRK) forecast ROE is 78.6%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.